Evidence map›Paper›PMID 27108600›Full record

ArticleOncology reports2016

Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines.

Syamalima Dube, Anish Thomas, Lynn Abbott, Patricia Benz, Charles Mitschow, Dipak K Dube, Bernard J Poiesz

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer.International journal of molecular sciences · 2019
    Review
  11. Article
  12. Sarcomeric TPM3α in developing chicken.Cytoskeleton (Hoboken, N.J.) · 2018
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Syamalima DubeDivision of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Anish ThomasDivision of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Lynn AbbottDivision of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Patricia BenzDivision of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Charles MitschowDivision of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Dipak K DubeDivision of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
Bernard J PoieszDivision of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.
SUNY Upstate Medical University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In humans, four tropomyosin genes (TPM1, TPM2, TPM3, and TPM4) are known to produce a multitude of isoforms via alternate splicing and/or using alternate promoters. Expression of tropomyosin has been shown to be modulated at both the transcription and the translational levels. Tropomyosins are known to make up some of the stress fibers of human epithelial cells and differences in their expression has been demonstrated in malignant breast epithelial cell lines compared to 'normal' breast cell lines. We have recently reported the expression of four novel TPM1 isoforms (TPM1λ, TPM1µ, TPM1ν, and TPM1ξ) from human malignant tumor breast cell lines that are not expressed in adult and fetal cardiac tissue. Also, we evaluated their expression in relation to the stress fiber formation. In this study, nine malignant breast epithelial cell lines and three 'normal' breast cell lines were examined for stress fiber formation and expression of tropomyosin 2 (TPM2) isoform-specific RNAs and proteins. Stress fiber formation was assessed by immunofluorescence using Leica AF6000 Deconvolution microscope. Stress fiber formation was strong (++++) in the 'normal' cell lines and varied among the malignant cell lines (negative to +++). No new TPM2 gene RNA isoforms were identified, and TPM2β was the most frequently expressed TPM2 RNA and protein isoform. Stress fiber formation positively correlated with TPM2β RNA or protein expression at high, statistically significant degrees. Previously, we had shown that TPM1δ and TPM1λ positively and inversely, respectively, correlated with stress fiber formation. The most powerful predictor of stress fiber formation was the combination of TPM2β RNA, TPM1δ RNA, and the inverse of TPM1λ RNA expression. Our results suggest that the increased expression of TPM1λ and the decreased expression of TPM1δ RNA and TPM2β may lead to decreased stress fiber formation and malignant transformation in human breast epithelial cells.

Indexed as

Alternative SplicingCell Transformation, NeoplasticFemaleGene ExpressionHumansMCF-7 CellsProtein IsoformsRNA, MessengerStress FibersTropomyosinProtein IsoformsRNA, MessengerTPM2 protein, humanTropomyosin

Identifiers

PMID27108600
PMCPMC4869935
OpenAlexW2337614059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.